Functional organization of the hematopoietic stem cell compartment: implications for cancer and its therapy.

1983 ◽  
Vol 1 (4) ◽  
pp. 277-284 ◽  
Author(s):  
S Hellman ◽  
U Reincke ◽  
L Botnick ◽  
P Mauch

Recent discoveries indicate that hematopoietic stem cells have limits on their proliferative capacity and are unable to divide indefinitely. There is great heterogeneity within the compartment as to the extent of this proliferative limitation. At any given time it appears that hematopoiesis is maintained by the progeny of only a few stem cells. When these are exhausted the progeny from other stem cells take their place. The observations of proliferative limitation, heterogeneity, and clonal succession must be incorporated into any model of stem cell organization. These new discoveries and the models incorporating them have important clinical implications. They may explain the inability of normal tissues to develop drug resistance and they also offer a mechanism by which cell renewal systems decrease the development of malignancies. In the selection of chemotherapeutic agents not only the effectiveness of the drug upon the tumor must be considered, but also how specific agents affect the stem cell compartment. These data have important implications in the use of bone marrow transplantation for both malignant and nonmalignant disease.

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 1551-1551
Author(s):  
Janina Ratajczak ◽  
Wu Wan ◽  
Rui Liu ◽  
Dong-Myung Shin ◽  
Magdalena Kucia ◽  
...  

Abstract Abstract 1551 Insulin-like growth factor-1 (Igf-1) or somatomedin is an important factor affecting proliferation of several types of cells, but its role in hematopoiesis remains controversial. Secretion of Igf-1 in the liver is stimulated directly by the growth hormone (GH)–GH receptor (GH-R) axis and indirectly by a high calorie diet. We have previously reported that Igf-1 does not directly stimulate proliferation of hematopoietic progenitors (J Clin Invest. 1994;94:320). However, our recent data indicate that Igf-1 stimulates proliferation of so-called very small embryonic-like stem cells (VSELs), that as we demonstrated, are the most developmentally primitive stem cells in adult bone marrow (BM) (Leukemia 2006;20:857) and may give rise to long-term repopulating hematopoietic stem cells (LT-HSCs) (Leukemia 2010; in press doi:10.1038/leu.2010.121). We envision that VSELs play a role in rejuvenation of the pool of tissue-committed stem cells in some tissues (e.g., HSCs and MSCs in BM) and we observed that the number of these cells in murine BM decreases with age. We also observed that erasure of the somatic imprint on some paternally imprinted genes (e.g., Igf2-H19 and RasGRF1) results in attenuation of insulin/insulin-like factors (e.g., Ins/Igf-1 signaling), keeps VSELs quiescent in BM, and protects them from uncontrolled proliferation. In the current work, to shed more light on the role of Igf-1 on hematopoiesis and stem cell compartment, we analyzed BM isolated from murine Laron dwarfs, which due to a genetic mutation in the GH-R, maintain very low levels of Igf-1 in peripheral blood (PB) and interestingly are long-living animals (Nature 2010;464:504). Analysis of PB cell counts, however, did not reveal any differences in the number of erythrocytes, platelets, and leucocytes between Laron dwarf mice and wild type controls. In striking contrast, however, we observed that Laron dwarf mice have in BM i) a ∼4–5-fold increase in the number of Sca-1+c-kit+lineage- (SKL) cells and ii) a >4-fold higher number of clonogenic CFU-Mix, CFU-GM, BFU-E, and CFU-Meg cells. Interestingly, Laron dwarfs also maintained ∼3-fold higher number of VSELs in BM tissue. Since the Igf-1 level is regulated by calorie uptake, these data shed new light on caloric restriction, senescence, and the hematopoietic stem cell compartment. Accordingly, we propose a new paradigm in which chronic Igf-1 deficiency somehow protects VSELs from age-related elimination from BM. This mimics a situation seen in chronic caloric restriction where the Igf-1 level is low and this results in longevity. Since the long-living Laron dwarf mice that maintain low levels of Igf-1 have higher numbers of VSELs and HSCs in BM, we postulate that chronically elevated levels of Igf-1, resulting e.g., from high calorie uptake, may lead to premature depletion of the stem cell pool, including VSELs and HSCs, and thus be responsible for premature aging. This hypothesis is currently being tested in animals that overexpress Igf-1, and interestingly, in contrast to IGF-1–deficient Laron dwarf mice, appear to have much shorter lifespans. Further studies are needed that will link the effect of chronic high Igf-1 signaling with the development of hematological malignancies. Of note, murine Laron dwarfs are significantly protected from developing cancer and human Laron dwarfs with chronic low Igf-1 level do not develop malignancies at all. Disclosures: No relevant conflicts of interest to declare.


Blood ◽  
1995 ◽  
Vol 86 (8) ◽  
pp. 2986-2992 ◽  
Author(s):  
G de Haan ◽  
B Dontje ◽  
C Engel ◽  
M Loeffler ◽  
W Nijhof

Abstract Because of the complexity of appropriate stem cell assays, little information on the in vivo regulation of murine stem cell biology or stemmatopoiesis is available. It is unknown whether and how in vivo the primitive hematopoietic stem cell compartment is affected during a continued increased production of mature blood cells. In this study, we present data showing that prolonged (3 weeks) administration of granulocyte colony-stimulating factor (G-CSF), which is a major regulator of mature granulocyte production, has a substantial impact on both the size and the location of various stem cell subset pools in mice. We have used the novel cobblestone area forming cell (CAFC) assay to assess the effects of G-CSF on the stem cell compartment (CAFC days 7, 14, 21, and 28). In marrow, in which normally 99% of the total number of stem cells can be found, G-CSF induced a severe depletion of particularly the most primitive stem cells to 5% to 10% of normal values. The response after 7 days of G-CSF treatment was an increased amplification between CAFC day 14 and 7. However, this response occurred at the expense of the number of CAFC day 14. It is likely that the resulting gap of CAFC day 14 cell numbers was subsequently replenished from the more primitive CAFC day 21 and 28 compartments, because these cell numbers remained low during the entire treatment period. In the spleen, the number of stem cells increased, likely caused by a migration from the marrow via the blood, leading to an accumulation in the spleen. The increased number of stem cells in the spleen overcompensated for the loss in the marrow. When total body (marrow and spleen) stem cell numbers were calculated, it appeared that a continued increased production of mature granulocytes resulted in the establishment of a higher, new steady state of the stem cell compartment; most committed stem cells (CAFC day 7) were increased threefold, CAFC day 14 were increased 2.3-fold, CAFC-day 21 were increased 1.8-fold, and the most primitive stem cells evaluated, CAFC day 28, were not different from normal, although now 95% of these cells were located in the spleen. Four weeks after discontinuation of the G-CSF treatment, the stem cell reserve in the spleen had returned to a normal level, whereas stem cell numbers in marrow had recovered to values above normal. This study shows that the primitive stem cell compartment is seriously perturbed during an increased stimulation of the production of mature blood cells.(ABSTRACT TRUNCATED AT 400 WORDS)


Blood ◽  
2000 ◽  
Vol 95 (7) ◽  
pp. 2446-2448 ◽  
Author(s):  
Christa E. Müller-Sieburg ◽  
Rebecca H. Cho ◽  
Hans B. Sieburg ◽  
Sergey Kupriyanov ◽  
Roy Riblet

Abstract Previously we reported that the size of the stem cell compartment (measured as LTC-IC) is 11-fold greater in DBA/2 than in C57BL/6 mice, and we identified genes that regulate the size of the stem cell pool. To determine whether stem cell intrinsic or extrinsic events account for these differences, we created chimeras by aggregating morulae from the strains C57BL/6 and DBA/2. In these chimeras stem cells of both genotypes are exposed to a common mixed environment. Thus, an equalization of stem cell frequencies is expected if stem cell extrinsic effects dominate. Conversely, the parental ratio of LTC-IC should be preserved if the regulation is stem cell autonomous. For each chimera, individual LTC-IC were genotyped on the clonal levels by analyzing their progeny. We found that most of the difference that regulates the size of the stem cell compartment was intrinsic.


Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 399-399 ◽  
Author(s):  
Monique Terwijn ◽  
Angèle Kelder ◽  
Arjo P Rutten ◽  
Alexander N Snel ◽  
Willemijn Scholten ◽  
...  

Abstract Abstract 399 In acute myeloid leukemia (AML), relapses originate from the outgrowth of therapy surviving leukemic blasts know as minimal residual disease (MRD). Accumulating evidence shows that leukemia initiating cells or leukemic stem cells (LSCs) are responsible for persistence and outgrowth of AML. Monitoring LSCs during and after therapy might thus offer accurate prognostic information. However, as LSCs and hematopoietic stem cells (HSCs) both reside within the immunophenotypically defined CD34+CD38- compartment, accurate discrimination between LSCs and HSCs is required. We previously showed that within the CD34+CD38- stem cell compartment, LSCs can be discriminated from HSC by aberrant expression of markers (leukemia associated phenotype, LAP), including lineage markers like CD7, CD19 and CD56 and the novel LSC marker CLL-1 (van Rhenen, Leukemia 2007, Blood 2007). In addition, we reported that flowcytometer light scatter properties add to even better detection of LSCs, allowing LSCs detection in AML cases lacking LAP (ASH abstract 1353, 2008). Using this gating strategy, we determined LSC frequency in 64 remission bone marrow samples of CD34+ AML patients. A stem cell compartment was defined as a minimum of 5 clustered CD34+CD38- events with a minimal analyzed number of 500,000 white blood cells. After first cycle of chemotherapy, high LSC frequency (>1 × 10-3) clearly predicted adverse relapse free survival (RFS, figure 1a). LSC frequency above cut-off led to a median RFS of 5 months (n=9), while patients with LSC frequency below cut-off (n=22) showed a significantly longer median RFS of >56 months (p=0.00003). In spite of the relatively low number of patients, again a high LSC frequency (>2 × 10-4) after the second cycle and after consolidation therapy predicted worse RFS: after second cycle, median RFS was 6 months (n=9) vs. >43 months for patients with LSC frequency below cut-off (p=0.004). After consolidation, these figures were 6 months (n=7) vs. >32 months (n=6, p=0.03). Although total blast MRD (leukemic blasts as % of WBC) is known to predict survival (N.Feller et al. Leukemia 2004), monitoring LSCs as compared to total blast MRD has two major advantages: the specificity is higher (van Rhenen et al. Leukemia 2007) and well-known LSC makers like CLL-1, CD96 and CD123 can in principle be used for LSC monitoring, but not for total blast MRD detection since these markers are also expressed on normal progenitor cells. On the other hand, LSCs constitute only a small fraction of all leukemic blasts and therefore monitoring total blast MRD may have the advantage of a higher sensitivity. We thus tested the hypothesis that even more accurate prognostic information could be obtained by combining LSC frequency with total blast MRD. Total blast MRD after first cycle was predictive for survival with borderline significance (p=0.08): a cut-off of 0.3% resulted in two patient groups with median RFS of 9 months vs. >56 months. Figure 1b shows the result of the combined data of LSC and MRD frequency after first cycle therapy. We used the terms LSC+ and MRD+ for cell frequencies above cut-off and LSC- and MRD- for those below cut-off. We could clearly identify that apart from LSC+/MRD+ patients, LSC+/MRD- patients too have very poor prognosis, while MRD+/LSC- patients show an adverse prognosis as compared to LSC-/MRD- patients. These results from the first study on the in vivo fate of LSCs during and after therapy, strongly support the hypothesis that in CD34+ AML the leukemia initiating capacity originates from the CD34+CD38- population and is important for tumor survival and outgrowth. These results show that LSC frequency might be superior in predicting prognosis of AML patients in CR as compared to MRD total blast frequency, while the combination of both may offer the most optimal parameter to guide future intervention therapies. This work was supported by Netherlands Cancer Foundation KWF. Disclosures: No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document